Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.68M | 15.47M | 14.96M | 14.19M | 12.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.68M | 15.47M | 14.96M | 14.19M | 12.92M |
| Cost of Revenue | 3.46M | 3.63M | 3.69M | 3.46M | 3.05M |
| Gross Profit | 12.22M | 11.85M | 11.26M | 10.73M | 9.86M |
| SG&A Expenses | 16.53M | 15.99M | 14.92M | 13.78M | 12.68M |
| Depreciation & Amortization | 946.20K | 867.60K | 899.40K | 874.80K | 853.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.88M | 20.42M | 19.45M | 18.05M | 16.43M |
| Operating Income | -5.20M | -4.94M | -4.49M | -3.86M | -3.51M |
| Income Before Tax | -6.71M | -6.91M | -6.36M | -5.52M | -5.84M |
| Income Tax Expenses | -611.40K | -611.40K | -611.40K | -596.90K | -50.70K |
| Earnings from Continuing Operations | -6.10 | -6.29 | -5.75 | -4.92 | -5.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.10M | -6.29M | -5.75M | -4.92M | -5.79M |
| EBIT | -5.20M | -4.94M | -4.49M | -3.86M | -3.51M |
| EBITDA | -4.47M | -4.30M | -3.81M | -3.19M | -2.87M |
| EPS Basic | -0.07 | -0.07 | -0.07 | -0.06 | -0.07 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.04 | -0.03 | -0.03 |
| EPS Diluted | -0.07 | -0.07 | -0.07 | -0.06 | -0.07 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.04 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 348.41M | 346.80M | 344.44M | 341.65M | 339.85M |
| Average Diluted Shares Outstanding | 366.42M | 359.81M | 360.76M | 348.97M | 347.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
